Clinical Trials

Keywords/SWOG Study Number

Area of Research

Accrual Status

Any

Open

Closed

Limit to SWOG Trials

All Trials

SWOG Trials Only

Show only published studies

Study Type

Treatment

Study Chair

Participating Institution

Phase

Cancer Control Subcommittee

Study Sponsor

FDA Registration Trial

Uses PRO Forms

647 Results

View

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer

Status Notes

This protocol will be permanently closed to accrual effective 10/1/15.

Research Committee(s)

Symptom Control and Quality of Life

Breast Cancer

Activated

05-15-2013

Closed

10-01-2015

ClinicalTrials.gov Registry Number

NCT01598298

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1115

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Research Committee(s)

Gastrointestinal Cancer

Activated

08-15-2012

Closed

05-15-2014

ClinicalTrials.gov Registry Number

NCT01658943

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1117

A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Research Committee(s)

Leukemia

Activated

03-01-2012

Closed

11-14-2014

ClinicalTrials.gov Registry Number

NCT01522976

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III

Research Committee(s)

Symptom Control and Quality of Life

Breast Cancer

Activated

02-01-2012

Closed

02-01-2013

ClinicalTrials.gov Registry Number

NCT01385137

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination

Research Committee(s)

Prevention & Epidemiology

Activated

12-02-2011

Closed

08-05-2013

ClinicalTrials.gov Registry Number

NCT01512875

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

Research Committee(s)

Lymphoma

Activated

10-28-2011

Closed

06-06-2013

Closed

Phase

Accrual

29%

Published

SWOG Clinical Trial Number

S1106

A Randomized Phase II Trial of R-HCVAD-MTX/ARA-C Induction Followed by Consolidation With an Autologous Stem Cell Transplant vs. R-Bendamustine Induction Followed by Consolidation With an Autologous Stem Cell Transplant for Patients </= 65 Years of Age With Previously Untreated Mantle Cell Lymphoma

Research Committee(s)

Lymphoma

Activated

10-01-2011

Closed

06-26-2013

ClinicalTrials.gov Registry Number

NCT01412879

Closed

Phase

Accrual

98%

Published

SWOG Clinical Trial Number

S1014

Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II.

Research Committee(s)

Genitourinary Cancer

Activated

08-09-2011

Closed

08-01-2013

ClinicalTrials.gov Registry Number

NCT01309672

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S1005

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer

Research Committee(s)

Gastrointestinal Cancer

Activated

01-01-2011

Closed

05-01-2013

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0925

A Randomized Phase II Study of Androgen Deprivation Combined with IMC-A12 Versus Androgen Deprivation Alone for Patients with New Hormone-Sensitive Metastatic Prostate Cancer

Research Committee(s)

Genitourinary Cancer

Activated

12-15-2010

Closed

12-01-2012

ClinicalTrials.gov Registry Number

NCT01120236

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0806

A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)

Research Committee(s)

Lymphoma

Activated

11-15-2010

Closed

10-01-2013

ClinicalTrials.gov Registry Number

NCT00972478

Closed

Phase

Accrual

45%

Published

SWOG Clinical Trial Number

S0933

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma

Research Committee(s)

Melanoma

Activated

10-28-2010

Closed

11-15-2011

ClinicalTrials.gov Registry Number

NCT01120275

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0910

A Phase II Study of Epratuzumab in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Precursor B-cell Acute Lymphoblastic Leukemia

Research Committee(s)

Leukemia

Activated

08-15-2010

Closed

07-01-2012

Closed

Phase

Accrual

73%

Published

SWOG Clinical Trial Number

S0941

Phase II Study of Sorafenib (NSC-724772) and Erlotinib (NSC-718781) in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma

Research Committee(s)

Gastrointestinal Cancer

Activated

04-15-2010

Closed

09-15-2011

ClinicalTrials.gov Registry Number

NCT01093222

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0800

A Randomized Phase II Trial of Weekly Nanoparticle Albumin Bound Paclitaxel (Nab-Paclitaxel) (NSC-736631) With or Without Bevacizumab, Either Preceded by or Followed by Q 2 Week Doxorubicin (A) and Cyclophosphamide (C) Plus Pegfilgrastim (Peg-G) as Neoadjuvant Therapy for Inflammatory and Locally Advanced Her-2/Neu Negative Breast Cancer

Research Committee(s)

Breast Cancer

Activated

04-01-2010

Closed

10-01-2012

Closed

Phase

Accrual

91%

Published

SWOG Clinical Trial Number

S0905

A Phase I / Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma

Status Notes

This study permanently closed to accrual February 15, 2016.

Research Committee(s)

Lung Cancer

Activated

03-15-2010

Closed

02-15-2016

ClinicalTrials.gov Registry Number

NCT01064648

Closed

Phase

Accrual

99%

Published

SWOG Clinical Trial Number

S0904

Randomized Phase II Study of Docetaxel Followed by Vandetanib (ZD6474) vs. Docetaxel plus Vandetanib in Patients with Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Research Committee(s)

Gynecologic Cancer

Activated

03-15-2010

Closed

08-01-2011

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0715

Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane Induced Neuropathy

Research Committee(s)

Symptom Control and Quality of Life

Breast Cancer

Cancer Survivorship

Molecular Epidemiology

Activated

09-15-2009

Closed

02-01-2011

Closed

Phase

Accrual

100%

Published

SWOG Clinical Trial Number

S0805

Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without Allogeneic Stem Cell transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL)

Research Committee(s)

Leukemia

Activated

09-01-2009

ClinicalTrials.gov Registry Number

NCT00390793

Closed

Phase

Accrual

78%

Published

SWOG Clinical Trial Number

S0819

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

Status Notes

Status Notes: NOTE: The url for ordering specimen kits for this study has changed. Please use the following link: https://ricapps.nationwidechildrens.org/KitManagement

Research Committee(s)

Lung Cancer

Activated

07-15-2009

Closed

05-01-2015

ClinicalTrials.gov Registry Number

NCT00946712

Clinical Trials

647 Results

Active Filters

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

A Randomized Phase II Study of Azacitidine in Combination with Lenalidomide (NSC-703813) vs. Azacitidine Alone vs. Azacitidine in Combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

A Randomized Phase II Trial of R-HCVAD-MTX/ARA-C Induction Followed by Consolidation With an Autologous Stem Cell Transplant vs. R-Bendamustine Induction Followed by Consolidation With an Autologous Stem Cell Transplant for Patients </= 65 Years of Age With Previously Untreated Mantle Cell Lymphoma

Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II.

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer

A Randomized Phase II Study of Androgen Deprivation Combined with IMC-A12 Versus Androgen Deprivation Alone for Patients with New Hormone-Sensitive Metastatic Prostate Cancer

A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma

A Phase II Study of Epratuzumab in Combination with Cytarabine and Clofarabine for Patients with Relapsed or Refractory Precursor B-cell Acute Lymphoblastic Leukemia

Phase II Study of Sorafenib (NSC-724772) and Erlotinib (NSC-718781) in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma

A Phase I / Randomized Phase II Study of Cediranib (NSC #732208) Versus Placebo in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Malignant Pleural Mesothelioma

Randomized Phase II Study of Docetaxel Followed by Vandetanib (ZD6474) vs. Docetaxel plus Vandetanib in Patients with Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Randomized Placebo-Controlled Trial of Acetyl L-Carnitine for the Prevention of Taxane Induced Neuropathy

Phase II Study of Combination of Hyper-CVAD and Dasatinib with or without Allogeneic Stem Cell transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leukemia (ALL)

A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)